General MedicationsINTRAMUSCULARStandard
LUPRON DEPOT-PED KIT
LEUPROLIDE ACETATE
Standard Dose
45MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview LUPRON DEPOT-PED KIT is listed in Drugs@FDA under application 020263 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient LEUPROLIDE ACETATE Form and strength POWDER;INTRAMUSCULAR - 45MG Sponsor ABBVIE ENDOCRINE INC Submission history Latest submission status date: 2025-11-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview LUPRON DEPOT-PED KIT is listed in Drugs@FDA under application 020263 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEUPROLIDE ACETATE Form and strength POWDER;INTRAMUSCULAR - 45MG Sponsor ABBVIE ENDOCRINE INC Submission history Latest submission status date: 2025-11-14 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.